相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
Sabela Bobillo et al.
HAEMATOLOGICA (2021)
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
Andres J. M. Ferreri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas
Anne-Katrin Hickmann et al.
BMC CANCER (2019)
Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis
V. Rimelen et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma
Jun Watanabe et al.
LEUKEMIA & LYMPHOMA (2019)
The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors
Austin K. Mattox et al.
NEURO-ONCOLOGY (2019)
MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma
Laura S. Hiemcke-Jiwa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
High Detection Rate of MYD88 Mutations in Cerebrospinal Fluid From Patients With CNS Lymphomas
Jun Watanabe et al.
JCO PRECISION ONCOLOGY (2019)
The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid
Laura S. Hiemcke-Jiwa et al.
HEMATOLOGICAL ONCOLOGY (2018)
Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis
Lucineia Gainski Danielski et al.
MOLECULAR NEUROBIOLOGY (2018)
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities
Laura S. Hiemcke-Jiwa et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma
Soheil Zorofchian et al.
FRONTIERS IN ONCOLOGY (2018)
Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma
Keiichiro Hattori et al.
CANCER SCIENCE (2018)
Brain Tumor Registry of Japan (2005-2008)
NEUROLOGIA MEDICO-CHIRURGICA (2017)
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
T. Nakamura et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)
Genomic characterization of primary central nervous system lymphoma
Kazutaka Fukumura et al.
ACTA NEUROPATHOLOGICA (2016)
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
Elena I. Pentsova et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Contemporary frameless intracranial biopsy techniques: Might variation in safety and efficacy be expected?
Iris S. C. Verploegh et al.
ACTA NEUROCHIRURGICA (2015)
Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations
So Yamada et al.
LEUKEMIA & LYMPHOMA (2015)
Frameless image-guided stereotactic brain biopsies: emphasis on diagnostic yield
Sodaba Khatab et al.
ACTA NEUROCHIRURGICA (2014)
Biobanking of CSF: International standardization to optimize biomarker development
Charlotte E. Teunissen et al.
CLINICAL BIOCHEMISTRY (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
W. Kraan et al.
BLOOD CANCER JOURNAL (2013)
Primary CNS lymphoma
Andres J. M. Ferreri et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2012)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)